Philip Morris International logo
  • Small text size
  • Medium text size
  • Large text size
  • Email
  • Print
  • PMI Global Site

Colombia

  • EN
  • ES
                                                                                            
cc1=true;cc3=true;cc4=true; 
Colombia

Contact Us

Head Office
Philip Morris Colombia S.A.
Calle 98 No. 10-28
Piso 7
Bogotá
Colombia

Tel: +57 1 651 64 64

Manufacturing Facility
Compania Colombiana de Tabaco S.A. (COLTABACO)
Carrera 52 No. 4-96
Medellín
Colombia

Tel: +57 4 3569000 
        +57 4 3565000

Consumer Information
Tel: 01 8005 1 81555

Careers

  • International Opportunities

Country Overview

Key Facts

Number of Employees: Approximately 1300

Main Brands:
Boston, Caribe, Green, Derby, Marlboro, Pielroja, American Gold

Welcome to Coltabaco, Philip Morris International’s (PMI) affiliate in Colombia. Our business was established in 1919 and became part of PMI in 2005. We are the biggest tobacco company in Colombia. We buy over 35% of Colombia’s tobacco leaf production, have a stemmery in Barranquilla, offices in 31 cities, and a production facility in Medellín. In total we employ around 1,300 people.

Coltabaco supports the local communities in which we live and work.  Through Dividendo for Colombia, Coltabaco developed the project Sembrando Futuro to meet the basic education needs of children who live in rural tobacco-growing areas. Today, more than 1,400 children from 37 rural schools and 81 teachers benefit from this assistance.

Smoking and Health

Tobacco products, including cigarettes, are dangerous and addictive. There is overwhelming medical and scientific evidence that smoking causes lung cancer, heart disease, emphysema, and other serious diseases.

Addiction

All tobacco products are addictive. It can be very difficult to quit smoking, but this should not deter smokers who want to quit from trying to do so.

Secondhand Smoke
Public health officials have concluded that secondhand smoke from cigarettes causes serious diseases in non-smokers, including lung cancer and heart disease. We believe the public health conclusions on secondhand smoke are sufficient to support smoking restrictions in public places.

Effective Regulation
Philip Morris International (PMI) supports comprehensive regulation of tobacco products based on the principle of harm reduction.

To be effective, tobacco regulatory policy must be evidence-based, apply to all tobacco products, and should take into account the views of all legitimate stakeholders including public health authorities, government finance authorities, tobacco manufacturers, and other members of the tobacco supply chain. Regulatory policy must consider the potential to trigger adverse consequences which undermine public health objectives, such as increasing the demand for illicit cigarettes. While we support comprehensive, effective tobacco regulation, we do not support regulation that prevents adults from buying and using tobacco products or that imposes unnecessary impediments to the operation of the legitimate tobacco market. In that regard, we oppose measures such as generic packaging, point of sale display bans, total bans on communications to adult consumers, and bans on the use of all ingredients in tobacco products. 

© 2002-2010 Philip Morris International Management SA